De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Avanos Medical Balans Gezondheid
Financiële gezondheid criteriumcontroles 6/6
Avanos Medical heeft een totaal eigen vermogen van $1.2B en een totale schuld van $175.1M, wat de schuld-eigenvermogensverhouding op 14.3% brengt. De totale activa en totale passiva bedragen respectievelijk $1.7B en $435.8M. De EBIT Avanos Medical is $73.4M waardoor de rentedekking 8.4 is. Het heeft contanten en kortetermijnbeleggingen van $92.2M.
Belangrijke informatie
14.3%
Verhouding schuld/eigen vermogen
US$175.10m
Schuld
| Rente dekkingsratio | 8.4x |
| Contant | US$92.20m |
| Aandelen | US$1.22b |
| Totaal verplichtingen | US$435.80m |
| Totaal activa | US$1.66b |
Recente financiële gezondheidsupdates
Is Avanos Medical (NYSE:AVNS) A Risky Investment?
Jan 05
We Think Avanos Medical (NYSE:AVNS) Can Manage Its Debt With Ease
Jun 05Is Avanos Medical (NYSE:AVNS) Using Too Much Debt?
Mar 02Is Avanos Medical (NYSE:AVNS) Using Too Much Debt?
May 03Avanos Medical (NYSE:AVNS) Takes On Some Risk With Its Use Of Debt
Sep 10We Think Avanos Medical (NYSE:AVNS) Is Taking Some Risk With Its Debt
Jun 09Recent updates
There May Be Some Bright Spots In Avanos Medical's (NYSE:AVNS) Earnings
Aug 07Lacklustre Performance Is Driving Avanos Medical, Inc.'s (NYSE:AVNS) Low P/S
Apr 17Is Avanos Medical (NYSE:AVNS) A Risky Investment?
Jan 05Some Avanos Medical, Inc. (NYSE:AVNS) Analysts Just Made A Major Cut To Next Year's Estimates
Aug 14When Should You Buy Avanos Medical, Inc. (NYSE:AVNS)?
Aug 13Avanos Medical: Leaning Up, Attractive Returns On Incremental Capital, Reiterate Buy
Jul 16We Think Avanos Medical (NYSE:AVNS) Can Manage Its Debt With Ease
Jun 05Avanos Medical, Inc. (NYSE:AVNS) Stocks Pounded By 26% But Not Lagging Market On Growth Or Pricing
May 18Avanos Medical (NYSE:AVNS) Is Looking To Continue Growing Its Returns On Capital
May 07Is Avanos Medical (NYSE:AVNS) Using Too Much Debt?
Mar 02Avanos Medical Q4 2022 Earnings Preview
Feb 20Avanos Medical, Inc. (NYSE:AVNS) Shares Could Be 30% Below Their Intrinsic Value Estimate
Feb 10Why Avanos Medical, Inc. (NYSE:AVNS) Could Be Worth Watching
Jan 13Avanos Medical reports Q3 mixed earnings; reaffirms FY22 guidance
Nov 02Avanos: Recent Entry To Hyaluronic Acid Market Sparks Interesting Debate
Sep 12Avanos Medical Q2 2022 Earnings Preview
Aug 08When Should You Buy Avanos Medical, Inc. (NYSE:AVNS)?
May 28Is Avanos Medical (NYSE:AVNS) Using Too Much Debt?
May 03Is There An Opportunity With Avanos Medical, Inc.'s (NYSE:AVNS) 41% Undervaluation?
Feb 10Should You Think About Buying Avanos Medical, Inc. (NYSE:AVNS) Now?
Dec 21An Intrinsic Calculation For Avanos Medical, Inc. (NYSE:AVNS) Suggests It's 33% Undervalued
Nov 04Avanos Medical (NYSE:AVNS) Takes On Some Risk With Its Use Of Debt
Sep 10The Strong Earnings Posted By Avanos Medical (NYSE:AVNS) Are A Good Indication Of The Strength Of The Business
Aug 10Is There Now An Opportunity In Avanos Medical, Inc. (NYSE:AVNS)?
Jun 30We Think Avanos Medical (NYSE:AVNS) Is Taking Some Risk With Its Debt
Jun 09Analyse van de financiële positie
Kortlopende schulden: De korte termijn activa ( $474.1M ) AVNS } overtreffen de korte termijn passiva ( $208.2M ).
Langlopende schulden: De kortetermijnactiva AVNS ( $474.1M ) overtreffen de langetermijnschulden ( $227.6M ).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: De netto schuld/eigen vermogen ratio ( 6.8% ) AVNS wordt als voldoende beschouwd.
Schuld verminderen: De schuld/eigen vermogen-ratio van AVNS is de afgelopen 5 jaar gedaald van 19.4% naar 14.3%.
Schuldendekking: De schuld van AVNS wordt goed gedekt door de operationele kasstroom ( 35.2% ).
Rentedekking: De rentebetalingen op de schuld van AVNS worden goed gedekt door EBIT ( 8.4 x dekking).